ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
UroGen’s urothelial cancer drug hits target, could prevent surgery
January 10, 2019Former Novartis oncology chief Liz Barrett’s decision to jump ship to lead the biotech UroGen appears to have been vindicated after the company announced top-line results showing its lead drug could change standard of care in a form of urothelial cancer. -
UroGen appoints former Novartis cancer chief Barrett as CEO
January 09, 2019Novartis’ former oncology CEO Liz Barrett has left to join a little known biotech, UroGen, to help bring its potential urothelial cancer drug to market.
Pharma Sources Insight January 2025
